Geared up to making us
very attractive

LU Bio has a clear exit strategy for all investments before we commit ourselves to running a project. We will only invest in inventions with an obvious exit potential within a maximum period of 4-5 years. A clear exit opportunity is an important goal as the pharmaceutical industry is very interested in in-licensing or purchasing new and potentially successful biomedical substances from biotech businesses such as ours.

During this period, resources will be allocated to obtain the best possible development and investment value. Our exit process will be executed in cooperation with an external advisor.
Naturally, all our efforts towards exit are geared up to adding value to both inventors and the investors to the benefit of all parties involved.